Literature DB >> 18174657

Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke.

Hirotsugu Ueshima1.   

Abstract

Japan's age-adjusted rate for mortality from stroke increased after the Second World War until 1965 and then showed a significant decline until 1990; however, the age-adjusted rate for mortality from all heart disease and coronary heart disease (CHD) increased until 1970 and then declined slowly. A puzzling question is why the rate of mortality from CHD declined in spite of an increase in serum total cholesterol level following an increase in fat consumption. It was confirmed that CHD incidence was far lower in several Japanese populations compared to Western countries in the " Monitoring Trends and Determinants in Cardiovascular Disease " (MONICA) project; therefore, the lower CHD mortality in Japan stems from the lower CHD incidence. CHD risk factors based on epidemiologic cohort studies in Japan were no different from those of other industrialized countries: hypertension, hypercholesterolemia, smoking and diabetes mellitus (DM). So, how can we explain this phenomenon?There are three possible explanations. One is the decline in population blood pressure level and the prevalence of hypertension during the years 1965-1990; the second is the decline in smoking rate in men and women; the third is that the serum total cholesterol level for middle-aged and elderly populations remains 5-15 mg/dL lower than that of the US elderly counterpart, although men aged 40-49 in Japan and the US had similar serum total cholesterol levels. It was also noted that elderly people in Japan, as observed in the Seven Countries Study, had far lower serum total cholesterol levels in midlife, i.e., around 160 mg/dL in the 1960s. This was not the case for elderly in the US where a higher serum total cholesterol level was observed in midlife. In conclusion, the lower serum cholesterol level in the past of Japanese middle-aged and elderly people compared to Western counterparts helps to maintain the low CHD incidence and mortality supported by the declining trend in blood pressure level and smoking rate for both men and women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18174657     DOI: 10.5551/jat.e529

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  70 in total

1.  Associations between aldehyde dehydrogenase 2 (ALDH2) genetic polymorphisms, drinking status, and hypertension risk in Japanese adult male workers: a case-control study.

Authors:  Mitsunori Ota; Aya Hisada; Xi Lu; Chihiro Nakashita; Shouta Masuda; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2015-08-30       Impact factor: 3.674

2.  Inequalities in noncommunicable disease mortality in the ten largest Japanese cities.

Authors:  Megumi Kano; Miyuki Hotta; Amit Prasad
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

3.  Secular trends of the impact of overweight and obesity on hypertension in Japan, 1980-2010.

Authors:  Masato Nagai; Takayoshi Ohkubo; Yoshitaka Murakami; Naoyuki Takashima; Aya Kadota; Naoko Miyagawa; Yoshino Saito; Nobuo Nishi; Nagako Okuda; Yutaka Kiyohara; Hideaki Nakagawa; Yoshikazu Nakamura; Akira Fujiyoshi; Robert D Abbott; Tomonori Okamura; Akira Okayama; Hirotsugu Ueshima; Katsuyuki Miura
Journal:  Hypertens Res       Date:  2015-07-16       Impact factor: 3.872

Review 4.  Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Masafumi Ihara; Albertino Damasceno; Adesola Ogunniyi; Catherine Dotchin; Stella-Maria Paddick; Julius Ogeng'o; Richard Walker; Raj N Kalaria
Journal:  Brain Res Bull       Date:  2018-05-25       Impact factor: 4.077

5.  Cross-sectional comparison of coronary artery calcium scores between Caucasian men in the United States and Japanese men in Japan: the multi-ethnic study of atherosclerosis and the Shiga epidemiological study of subclinical atherosclerosis.

Authors:  Akira Fujiyoshi; Katsuyuki Miura; Takayoshi Ohkubo; Takashi Kadowaki; Sayaka Kadowaki; Maryam Zaid; Takashi Hisamatsu; Akira Sekikawa; Matthew J Budoff; Kiang Liu; Hirotsugu Ueshima
Journal:  Am J Epidemiol       Date:  2014-08-13       Impact factor: 4.897

6.  Preoperative smoking cessation can reduce postoperative complications in gastric cancer surgery.

Authors:  Kuk Hyun Jung; Su Mi Kim; Min Gew Choi; Jun Ho Lee; Jae Hyung Noh; Tae Sung Sohn; Jae Moon Bae; Sung Kim
Journal:  Gastric Cancer       Date:  2014-08-20       Impact factor: 7.370

7.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

8.  The 2014 hypertension guidelines: implications for patients and practitioners in Asia.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Paolo Verdecchia
Journal:  Heart Asia       Date:  2015-11-24

9.  Risk factor effects and total mortality in older Japanese men in Japan and Hawaii.

Authors:  Robert D Abbott; Hirotsugu Ueshima; Atsushi Hozawa; Tomonori Okamura; Takashi Kadowaki; Katsuyuki Miura; Nagako Okuda; Yasuyuki Nakamura; Akira Okayama; Yoshikuni Kita; Beatriz L Rodriguez; Katsuhiko Yano; J David Curb
Journal:  Ann Epidemiol       Date:  2008-12       Impact factor: 3.797

10.  High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes.

Authors:  Natsuo Tomita; Norihito Soga; Yuji Ogura; Norio Hayashi; Takumi Kageyama; Makoto Ito; Yutaro Koide; Maiko Yoshida; Kana Kimura; Chiyoko Makita; Hiroyuki Tachibana; Takeshi Kodaira
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-02       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.